Sysmex Customer Satisfaction Ranks Highest in Independent Market Research

2009/02/24

Media Contact: Tammy Kutz, Manager, Media & Events
   Sysmex America, Inc.
   communications@sysmex.com

 

Mundelein, Illinois – February 24, 2009 – Sysmex America, Inc., a leading medical diagnostic instrument manufacturer and laboratory information systems developer today announced that Sysmex hematology instruments have been ranked best in industry for instrument reliability for its ninth consecutive year according to IMV’s 2008 ServiceTrak™ report.  In this annual report, Sysmex also ranked first in 21 (twenty-one) of the 30 (thirty) survey factors, including all five OEM (Original Equipment Manufacturer) service performance factors and all five manufacturer and instrument performance factors.  The IMV ServiceTrak survey respondents include clinical laboratory department supervisors, laboratory managers, and technologists chosen at random from hospitals of varying sizes from across the country.  Sysmex hematology instruments also ranked first in customer satisfaction in MD Buyline’s January 2009 User Satisfaction Ratings.  MD Buyline survey respondents include technologists and clinicians from hospitals and clinical reference laboratories located throughout the United States. 

“In today’s tougher economic environment, clinical laboratories must aggressively seek core laboratory efficiency that ultimately contributes to the hospital’s overall healthcare efficiency.  Indicators such as IMV ServiceTrak and MD Buyline results are crucial information for clinical laboratories,” said John Kershaw, President, Sysmex America, Inc.  “For example, instrument reliability is a performance indicator that directly affects efficiency in patient care areas, including the emergency department, where speed is essential and operational costs are high,” said Kershaw.  

Instrument reliability also impacts clinical laboratory performance metrics such as results turnaround time and repeat rate.  Switching to backup analyzers could create issues with shifting normal ranges and consistency of results used in patient trending analysis.  Therefore, clinical laboratories will want to assess their instrument capability relative to their effect on service lines, care pathways, medical errors and patient flow, said Kershaw.

   
“Regardless of the healthcare industry’s economic concerns, we know our customers must provide high quality care for their patients.  As a healthcare partner to many of the nation’s healthcare facilities, we are honored that our hematology instruments have met their needs in reliability and performance expectations,” added Kershaw.

 

For more information about Sysmex hematology instruments and services, visit www.sysmex.com/usa.

About Sysmex America, Inc.
Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems.  Serving customers for over 35 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide.  For more information about Sysmex, please visit www.sysmex.com/usa.